Abstract Background: Vitamin D (Vit D) is linked to various conditions including musculoskeletal, metabolic and cardiopulmonary diseases. However, it is not clear whether correction of vit D deficiency exerts any beneficial effect in patients with pulmonary hypertension. Methods: This...
A significant proportion of patients with hyperthyroidism may have mild pulmonary hypertension (PH), according to the results of a recent study. Increased pulmonary vascular resistance may be the underlying cause of this association. The study, “Relationship Among Pulmonary Hypertension,...
Professor Daniel Chambers from the Queensland Lung Transplant Service, at The Prince Charles Hospital in Brisbane, Australia, debunks 10 myths about lung transplants for pulmonary hypertension patients and other patients with lung problems. Read about five of the myths here: Lung transplant was considered “revolutionary” when...
by Dr. Stylianos E Orfanos This week (19th-27th November) in the UK is Pulmonary Hypertension awareness week. The theme for this year is “Let’s talk about PH” so we thought we’d do just that by inviting Dr. Stylianos E. Orfanos, Professor...
By Meredith Salisbury | July 26, 2016, 10:59 AM | Techonomy Exclusive Solving any disease is hard, but solving rare disease is a special kind of torture. Take everything that must be accomplished with any old disease—What causes it?...
Pulmonary hypertension (PH) is a rare, life-threatening disease that affects the pulmonary arteries, the lungs, and the heart. Patients who suffer from the disease have narrow and obstructed pulmonary arteries — the vessels responsible for transporting blood from the heart to the...
By MAGDALENA KEGEL Blocking the enzyme sphingosine kinase 1 (SK1) reduced right ventricle enlargement in a mouse model of pulmonary arterial hypertension (PAH), while having no impact on blood vessel remodeling. The findings, published in the journalCellular Signalling, highlighted disease...
By Patricia Inacio, PhD Galectin-3 (Gal-3) and the hormone aldosterone are two potentialbiomarkers for disease progression in patients with pulmonary arterial hypertension, according to a recent study, “Galectin-3 and aldosterone as potential tandem biomarkers in pulmonary arterial hypertension,” published in the journal...
By DANIELA SEMEDO, PHD Work on a doctoral dissertation at Umeå University in Sweden led to the discovery of new blood biomarkers reflecting vasoreactivity in lung blood vessels of patients with heart and lung disease, which can lead to simplified diagnostics and better...
BY MAGDALENA KEGEL Right ventricular dysfunction is intimately linked to pulmonary hypertension (PH). Since the dynamics of the two ventricles of the heart are connected through the shared tissue of the septum – the wall between the two ventricles – the team behind...
